We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Stenting for Restenotic Lesions with the BARD XT Stent.
- Authors
RAHEL, BRAIM M.; SUTTORP, MAARTEN J.; TE RIELE, HANS A.M.; BAL, EGBERT T.; ERNST, SJEF M. P. G.; MAST, E. GIJS; TEN BERG, JURRIËN M.; KELDER, JOHANNES C.; THIJS PLOKKER, H.W.
- Abstract
Background : Conventional PTCA for the treatment of restenotic lesions is associated with a high rate of recurrence (30–50%). Primary stenting decreases the restenosis rate at long-term follow-up. Methods : One-hundred consecutive patients with restenosis received a Bard XT stent. Follow-up angiography was performed after 6 months. Angiograms were compared by means of computed quantitative analysis. Results : The mean pretreatment reference diameter was 2.88 ± 0.51 mm . The mean minimal luminal diameter (MLD) increased from 1.09 ± 0.57 mm to 2.70 ± 0.44 mm . The percent diameter stenosis decreased from 66 ± 13% to 15 ± 10% . The procedural success rate was 99%. At 6 month follow-up repeat angiography was performed in 86 patients. The mean MLD was 1.74 ± 0.67 mm with a mean diameter stenosis of 41 ± 20%. Residual anginal complaints were reported in 29% of patients. In-stent restenosis (defined as diameter stenosis of more than 50%) occurred in 18% of the patients. Conclusion : Placement of the Bard XT stent in restenotic lesions is feasible, has an excellent short term outcome and yields a favorable result at 6 month follow-up angiography. (J Interven Cardiol 2003;16:227–230).
- Subjects
ANGIOGRAPHY; SURGICAL stents
- Publication
Journal of Interventional Cardiology, 2003, Vol 16, Issue 3, p227
- ISSN
0896-4327
- Publication type
Article
- DOI
10.1034/j.1600-0854.2003.8050.x